Support Research

President's Research Report wordmark

Scientific research is the front-line weapon in eliminating the terrible toll of lung disease on our families and loved ones. Through research, we strive to find better methods of detection, treatment and ultimately cures to a host of lung diseases, including asthma, chronic obstructive pulmonary disease (COPD) and lung cancer.

Consider these facts:

  • During 2014, close to 160,000 deaths from lung cancer were reported, representing more than 27 percent of all cancer deaths.
  • Asthma affects more than 6.8 million children under 18, and more than half of those have experienced an asthma attack during the previous year.
  • COPD (chronic bronchitis and emphysema) is the third leading cause of death in America, just behind heart disease and cancer.

Researchers Fighting Lung Disease

Research Awards Nationwide highlights research we support through our Awards and Grants Program and Asthma Clinical Research Centers (ACRC). This year, we will spend $9 million in lung disease research, supporting 85 novel and innovative research projects. Meet some of our researchers:

Smoking Asthmatics Pilot Study (SAPS)

About 20 percent of people with asthma smoke, yet smokers are consistently excluded from therapeutic trials for asthma. As a result current asthma treatment guidelines may not be appropriate for smokers. There is evidence that suggests that inhaled corticosteroids, the mainstay for treating persistent asthma, are less effective in smokers. The SAPS trial is designed to test the feasibility of a large scale clinical trial looking at the four main therapeutic options for asthmatic patients who still smoke and are not well controlled on standard asthma therapy. Smoking cessation remains the primary strategy for treating these patients but this study represents an important step toward improving care for that significant population of individuals with asthma for whom smoking cessation remains a struggle. Learn more about Airways Clinical Research Centers studies »

LUNG FORCE

Lung cancer is an urgent health crisis in America, killing more people than any other cancer. LUNG FORCE is making lung cancer a national priority. We've significantly increased our lung cancer research funding and are continually developing and improving support resources for lung cancer patients and their caregivers.

The LUNG FORCE initiative will:

  • Invest $10 million in lung cancer research and $5 million in increasing public health promotion, including awareness of early detection tools such as CT screening.
  • Provide patients with information about clinical trials and biomarker testing.
  • Advocate for increasing federal funding for lung cancer research from $213 million today to $300 million by 2020.

Learn more about LUNG FORCE »

Our mission to save lives by improving lung health and preventing lung disease is sustained by the important lung disease research projects we fund each year. This research, made possible through your enduring and generous support, is the key to our lifesaving mission.

Make a Donation